K94 Discoveries Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $300K
Latest Deal Amount
  • Investors
  • 1

K94 Discoveries General Information


Developer of novel targeted therapies intended to treat pancreatic cancer. The company's therapies combine the naturally-occurring anticancer substance curcumin with luteinizing hormone-releasing hormone (LHRH) that targets the hormone receptors present in large numbers on the surface of cancer cells, enabling physicians to conduct research in ovarian and breast cancer and treat their patients without any harmful effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Baton Rouge, LA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

K94 Discoveries Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 24-Sep-2013 $300K 00000 Completed Startup
To view K94 Discoveries’s complete valuation and funding history, request access »

K94 Discoveries Executive Team (2)

Name Title Board Seat Contact Info
William Hansel Ph.D Scientific Founder
Ross Barrett JD Interim President
To view K94 Discoveries’s complete executive team members history, request access »

K94 Discoveries Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BVM Capital Venture Capital Minority 000 0000 000000 0
To view K94 Discoveries’s complete investors history, request access »